Back to Trades
Fromkin Andrew J.
DirectorCIK 0001341896
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 4
- Companies
- 1
- Active
- 2025–2026
Fromkin Andrew J., Director, has filed 3 SEC reports (2025–2026), all concentrated in Immunovant, Inc. (IMVT), totaling $11.4M in disclosed volume. Weighing $0 bought versus $8.0M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| May 29 | IMVT Immunovant, Inc. | Fromkin Andrew J. | Director | Sell | $7.4M |
| Apr 9 | IMVT Immunovant, Inc. | Fromkin Andrew J. | Director | Grant | $173.8K |
| Dec 3 | IMVT Immunovant, Inc. | Fromkin Andrew J. | Director | Sell | $517.2K |
3 filings